Bayer Lotrimin and Tinactin Benzene Settlement — $4.85 Million Available
Bayer has agreed to pay $4.85 million to settle a class action lawsuit alleging that its Lotrimin AF and Tinactin antifungal spray products contained benzene, a known carcinogen. Consumers who purchased these products may file a claim for a refund by March 11, 2026.
What Is the Benzene Contamination Claim?
Independent testing revealed elevated levels of benzene in certain Bayer antifungal aerosol spray products, including Lotrimin AF and Tinactin. Bayer voluntarily recalled affected lots in 2021. The lawsuit alleges consumers were misled about product safety and paid a premium price for products that were adulterated with a carcinogen.
Who Is Eligible?
You may be eligible if you purchased Lotrimin AF Spray or Tinactin Antifungal Spray in the United States during the covered class period. You do not need a receipt to file a claim, though having proof of purchase may increase your reimbursement amount.
How Much Can You Receive?
Eligible claimants can receive a cash refund per unit purchased. Without proof of purchase, claimants may still receive a smaller flat-rate payment. With receipts or other documentation, the reimbursement is higher. The total available fund is $4.85 million shared among all valid claimants.
How to File Before the Deadline
File your claim at antifungalspraysettlement.com. The deadline is March 11, 2026 — act quickly as this deadline is approaching fast.
- Claim Deadline: March 11, 2026
- Settlement Fund: $4.85 million
- Official Site: antifungalspraysettlement.com
OpenClassActions.org is not affiliated with Bayer or the settlement administrator. This is for informational purposes only.
View the Bayer Lotrimin/Tinactin antifungal settlement on OpenClassActions.com.